(Q56601579)
Statements
N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I (English)
Kevin S Thorneloe
Anthony C Sulpizio
Zuojun Lin
David J Figueroa
Angela K Clouse
Gerald P McCafferty
Tim P Chendrimada
Erin S R Lashinger
Earl Gordon
Louise Evans
Blake A Misajet
Douglas J Demarini
Josephine H Nation
Robert W Marquis
Bartholomew J Votta
Steven A Sheardown
Xiaoping Xu
David P Brooks
Nicholas J Laping
Timothy D Westfall